Retour
46
Fourchette du Jour
19,00 €
21,00 €
Fourchette 52 Semaines
18,57 €
35,00 €
Volume
760
Moyenne 50J / 200J
20,95 €
/
25,69 €
Clôture Précédente
21,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 9,8 | 0,2 |
| P/B | 1,6 | 3,0 |
| ROE % | 17,8 | 3,6 |
| Net Margin % | 12,1 | 3,8 |
| Rev Growth 5Y % | 53,2 | 9,9 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,00 €
0,00 € – 0,00 €
|
3,90B | 0 |
| FY2029 |
22,48 €
20,58 € – 23,66 €
|
3,26B | 1 |
| FY2028 |
10,80 €
9,89 € – 11,37 €
|
2,53B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | 0,09 € | 0,07 € | -24,6% |
| 2025-10-23 | 0,09 € | 0,05 € | -35,6% |
| 2025-07-15 | 0,08 € | 0,08 € | +6,7% |
| 2025-04-23 | N/A | 0,02 € | — |
| 2025-02-25 | N/A | 0,07 € | — |
| 2024-10-24 | N/A | 0,04 € | — |
| 2024-07-11 | N/A | 0,04 € | — |
| 2024-04-25 | N/A | 0,03 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 53,17% annually over 5 years — strong growth
ROE of 17,81% — decent returns on equity
Debt/Equity of 0,01 — conservative balance sheet
Generating 218,19M in free cash flow
P/E of 9,75 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 22,80%
Croissance
Revenue Growth (5Y)
53,17%
Revenue (1Y)30,37%
Earnings (1Y)6,01%
FCF Growth (3Y)N/A
Qualité
Return on Equity
17,81%
ROIC23,61%
Net Margin12,10%
Op. Margin23,55%
Sécurité
Debt / Equity
0,01
Current Ratio4,85
Interest Coverage8,60
Valorisation
P/E Ratio
9,75
Forward P/E4,55
P/B Ratio1,60
EV/EBITDA3,69
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 30,37% | Revenue Growth (3Y) | 40,80% |
| Earnings Growth (1Y) | 6,01% | Earnings Growth (3Y) | -23,93% |
| Revenue Growth (5Y) | 53,17% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,17B | Net Income (TTM) | 141,80M |
| ROE | 17,81% | ROA | 13,72% |
| Gross Margin | 92,57% | Operating Margin | 23,55% |
| Net Margin | 12,10% | Free Cash Flow (TTM) | 218,19M |
| ROIC | 23,61% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 4,85 |
| Interest Coverage | 8,60 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 9,75 | Forward P/E | 4,55 |
| P/B Ratio | 1,60 | P/S Ratio | 1,18 |
| PEG Ratio | 21,62 | Forward PEG | N/A |
| EV/EBITDA | 3,69 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,93 | Fwd Earnings Yield | 21,98% |
| FCF Yield | 15,78% | ||
| Market Cap | 1,38B | Enterprise Value | 1,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,17B | 898,73M | 591,08M | 328,82M | 212,89M |
| Net Income | 141,80M | 133,75M | 245,02M | -68,17M | -85,53M |
| EPS (Diluted) | 2,12 | 2,01 | 3,74 | -1,06 | -1,34 |
| Gross Profit | 1,08B | 832,25M | 540,92M | 297,71M | 189,70M |
| Operating Income | 275,98M | 166,15M | 13,93M | -64,54M | -80,67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,03B | 879,69M | 688,82M | 371,82M | 343,92M |
| Total Liabilities | 168,46M | 152,23M | 143,64M | 102,89M | 78,22M |
| Shareholders' Equity | 865,08M | 727,46M | 545,18M | 268,93M | 265,70M |
| Total Debt | 11,68M | 14,59M | 17,48M | 17,45M | 21,42M |
| Cash & Equivalents | 377,04M | 227,00M | 166,93M | 201,28M | 206,46M |
| Current Assets | 794,66M | 622,60M | 402,94M | 338,81M | 308,48M |
| Current Liabilities | 163,91M | 144,19M | 130,06M | 90,20M | 61,70M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#488 of 1049
Activité Récente
Sorti
Contrarian Investing (David Dreman)
Mar 26, 2026
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026